3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
8
Anxiety Disorders
6
Neoplasms
5
Fatigue
4
Lymphoma
3
Depression
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Nervous System Diseases
2
Lymphoma, Follicular
2
Glioma
2
Weight Loss
1
Weight Gain
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Mental Disorders
1
Meningioma
1
Melanoma
1
Medication Adherence
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Interventions
Magnetic Resonance Spectroscopy
7
lutetium Lu 177 dotatate
6
Specimen Handling
5
Bevacizumab
4
gallium Ga 68 dotatate
3
abemaciclib
3
Radiosurgery
3
Proton Therapy
3
Nivolumab
3
pembrolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Protons
2
Observation
2
ONC206
2
Ipilimumab
2
Hydroxyurea
2
Ga(III)-DOTATOC
2
Everolimus
2
Elasticity Imaging Techniques
2
CTLA-4 Antigen
2
ribociclib
1
regorafenib
1
olaparib
1
neratinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
capivasertib
1
cabozantinib
1
brigatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
Cognitive Behavioral Therapy
×
1 year
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled